Skip to main content

$1.23 -0.02 (-1.21%)

High

$1.29

Low

$1.18

Trades

155

Turnover

$303,224

Volume

249,053
30 June 2023 at 4:10pm
Register to track RAC and receive email alerts.
Subject
RAC Ann: Expanded Heart Protection Discovery for Zantrene

RAC Ann: Notification regarding unquoted securities - RAC

RAC Ann: Race online Q&A investor briefing invitation

RAC Ann: Ceasing to be a substantial holder

RAC Ann: Change in substantial holding

RAC Ann: Race Oncology Investor Presentation - November 2021

RAC Ann: Race Oncology Share Purchase Plan Opens

RAC Ann: Cleansing Notice Pursuant to Share Purchase Plan

RAC Ann: Proposed issue of securities - RAC

RAC Ann: Race Oncology Share Purchase Plan

RAC Ann: Results of Annual General Meeting

RAC Ann: AGM Presentations

RAC Ann: Trading Halt

RAC Ann: Breakthrough Zantrene Heart Protection Discovery

RAC Ann: Appendix 3Y - Dr John Cullity

RAC Ann: Cleansing Notice

RAC Ann: Application for quotation of securities - RAC

RAC Ann: University of Wollongong R&D Collaboration

RAC Ann: Appendix 3Y - Dr John Cullity

RAC Ann: Companion Diagnostic Study Initiated with UON

RAC Ann: Ethics submission to commence Phase 2 AML EMD Trial

RAC Ann: Quarterly Activity Report & Appendix 4C

RAC Ann: Race-Chaim Sheba FTO Biomarker Collaboration

RAC Ann: Annual Report to shareholders

RAC Ann: Letter to Shareholders & Notice of Annual General Meeting

RAC Ann: Race secures sixth US patent for Zantrene

RAC Ann: Trading Policy Update

RAC Ann: Race secures fifth US patent for Zantrene

RAC Ann: Date of AGM & Closing Date for Director Nominations

RAC Ann: Preclinical & Clinical Programs Update

RAC Ann: Zantrene highly effective in Melanoma preclinical study

RAC Ann: Appendix 3Y - Dr John Cullity

RAC Ann: Annual Report-ASX Additonal Information Updated

RAC Ann: Appendix 4G

RAC Ann: Appendix 4E & Annual Report

RAC Ann: Appendix 3Y - Dr John Cullity

RAC Ann: Cleansing Notice

RAC Ann: Application for quotation of securities - RAC

RAC Ann: First Patient Dosed in Phase 1b/2 AML Trial

RAC Ann: Change in substantial holding

RAC Ann: Quarterly Activity Report & Appendix 4C

RAC Ann: Notification regarding unquoted securities - RAC

RAC Ann: Cleansing Notice

RAC Ann: Application for quotation of securities - RAC

RAC Ann: Notification regarding unquoted securities - RAC

RAC Ann: Appendix 3Y - Mary Harney

RAC Ann: Cleansing Notice

RAC Ann: Appendix 2A

RAC Ann: Race executes Israel AML Phase 2 Trial Contract

RAC Ann: Race Executes Key Contract for Israel Phase 2 AML Trial

Register to track RAC and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
TLX